F5, Inc. Other Income (Expense) increased by 16.8% to $10.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.1%, from $12.30M to $10.20M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 56.4% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.16M | -$2.87M | -$2.43M | -$1.93M | -$6.22M | -$7.81M | $4.70M | $2.74M | $2.90M | $3.09M | $9.88M | $5.97M | $8.53M | $12.49M | $3.96M | $12.30M | $16.71M | $9.42M | $8.74M | $10.20M |
| QoQ Change | — | -32.5% | +15.1% | +20.4% | -221.7% | -25.6% | +160.2% | -41.8% | +5.8% | +6.5% | +220.3% | -39.5% | +42.8% | +46.4% | -68.3% | +210.5% | +35.8% | -43.6% | -7.2% | +16.8% |
| YoY Change | — | — | — | — | -187.6% | -172.7% | +293.4% | +241.5% | +146.6% | +139.5% | +110.2% | +118.3% | +194.5% | +304.8% | -59.9% | +105.9% | +95.9% | -24.6% | +120.5% | -17.1% |